Enabling Our Clients
As businesses reopen, students get back into the classroom, sports teams look to compete, and companies aim to provide seamless service for their customers and clients, safety and confidence are top of mind. In an uncertain time, CoVerify Health is a highly reliable COVID-19 testing platform that is mindful of the health and business needs of our clients and communities.
What We Offer
CoVerify Health works with CLIA-certified clinical laboratory partners that have secured the FDA’s emergency use authorization (EUA) for Molecular-Based Tests (LDTs) for the Coronavirus Disease 2019 (COVID-19).
Our technology partners provide our customers with a platform for registration and consent, reporting symptoms, tracking and scheduling testing, organizing test results, notifying clients of regional outbreaks and more.
Utilize our qualified service provider network to order tests and coordinate sample collection efforts at a convenient location. Test kits arrive in as little as 24 hours.
Ongoing support to help design and complete your COVID-19 testing strategy.
We understand time is of the essence. Companies receive test results in as little as 24-48 hours from when tests are received by the lab.
Testing is done at a location that works best for you and your employees. Each employee can be initially tested prior to returning to work with subsequent testing scheduled in advance. Alternatively, testing can be scheduled on an as needed basis.
Both the employer and the individual tested are notified of test results and can immediately access reports via email notifications or through a secure online portal.
CoVerify Health schedules regular check-ins to continue to help guide your company’s COVID-19 testing strategy, enabling you to keep your employees feeling safe and confident.
CoVerify Health collects information about your business and works with you to develop your COVID-19 testing strategy.
Guidance to help you effectively communicate your COVID-19 testing plan to your employees. Consent forms are signed. Tests are ordered.
“Symptom monitoring is unlikely to detect more than about half of infections, and people may only develop symptoms days after being contagious.”
-Scott Gottlieb, MD, former FDA comm.
“The next steps are rapid testing and contact tracing.”
-Dr. Robert Bollinger, JHU Prof. of Infectious Diseases
The CDC has estimated that 35% of COVID-19 infections are asymptomatic.